CHIEF COMPLAINT

S/S MANIFESTED BY THE PATIENT

S/S NOT MANIFESTED BY THE PATIENT PHYSICAL EXAMINATION
LABORATORY & DIAGNOSTIC STUDIES Lungs/Chest: Rales/Crackles/Ronchi CC: Body we
MEDICATIONS on RLLF
PHYSICAL EXAMINATION
DISEASE PROCESS

July 22, 2021 7:45 P.M CBC

Segmenters 0.79 (H)
Lymphocytes 0.06 (L)
Monocytes 0.15 (H)
CRP 54 mg/L
Ferritin > 1000 ng/ml

P.C.C.E
Azithromycin 500 mg/tab Ceftria

Home meds:
Cefixime 100mg BID
July 22, 2021 7:05 P.

PH= 7.36, PCO2= 18, PO

July 25, 2021 4:49 A

PH= 7.38, PCO2= 26, PO
 CC: Body weakness, Cough, Fever

Inhalation of
M CBC bacteria, fungi, virus

H)
L)
H)
/L
Bacteria Proliferation
ng/ml

Cough reflex
Ceftriaxone 2gm IV OD Colonization of bacteria

Methionine Endotoxins

Tissue damage

Leukotriene
 L + b4

Chemotactic agent
2021 7:05 P.M ABG

6, PCO2= 18, PO2= 149, HCO3= 9.8 Respiratory smo

2021 4:49 A.M ABG

, PCO2= 26, PO2= 139, HCO3= 15.4

DOB, DY
 July 22, 2021 5:25 P.M CHEST AP PORTABLE

Impression: Peripheral opacities both lungs

suggestive of pneumonia
liferation

IgA Macrophages
f bacteria

damage

otriene
L + C4 L + D4 L+ E4
Respiratory smooth muscle

Bronchospasm

DOB, DYSPNEA
g
AP PORTABLE

oth lungs
Interleukin-8
 Inflammatory response

\
 Binded to Vascular permeability
endothelial cells

Mast cells
Histamine
Chemotactic agent
Cytokines Interleukin-1,
TNFa
permeability Inflammation

Congestion

July 22, 202

Hemoglobin
Hematocrit
iiiii RBCCongesti
(

trtrtrtrtr
Interleukin-1, FEVER

Paracetamol 500mg
 Exudative fluid
gestion

July 22, 2021 7:45 P.M, CBC

Hemoglobin 91.0 g/dL (L) Consolidation

Hematocrit 0.25 (L)
RBCCongestion3.2 (L)
TACHYPN
 FEVER

tamol 500mg/tab
 Pulmonary
Capillary damage

Consolidation
 Red hepatization

TACHYPNEA

Gray hepatization
Resolution
 COUGH

Acetylcysteine 600
mg/tab